TCL Archive Yervoy-Nivolumab Combination Treatment Shrinks Tumors 80 Percent in Three Months May 31, 2013
TCL Archive ODAC’s Dilemma: Proposed Indication Created By Reliance On PSA Screening and Hormonal Treatment September 23, 2011